I agree that this site is using cookies. You can find further informations here.
X
Loupakis, F.
129  results:
Search for persons X
?
1

257P A low fT3/fT4 ratio as a negative prognostic factor in..:

Scafetta, R. ; Loupakis, F. ; Marsicano, R.M....
ESMO Open.  9 (2024)  - p. 103278 , 2024
Link: https://doi.org/10.1016/..
 
?
2

29P fT3/fT4 ratio, systemic inflammation and skeletal muscl..:

Tuninetti, V. ; Virano, E. ; Calvo, A....
ESMO Open.  9 (2024)  - p. 103529 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Quality of life with encorafenib plus cetuximab with or wit..:

Kopetz, S. ; Grothey, A. ; Van Cutsem, E....
ESMO Open.  7 (2022)  3 - p. 100477 , 2022
Link: https://doi.org/10.1016/..
 
?
4

The impact of COVID-19 pandemic on healthcare workers' ment..:

Cerioli, M. ; Gesi, C. ; Di Maio, M....
Neuroscience Applied.  1 (2022)  - p. 100896 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Intratumor morphologic and transcriptomic heterogeneity in ..:

Angerilli, V. ; Fontana, E. ; Lonardi, S....
ESMO Open.  6 (2021)  4 - p. 100211 , 2021
Link: https://doi.org/10.1016/..
 
?
6

PO-472 MicroRNA as biomarkers of resistance to regorafenib ..:

Hedayat, S. ; Khan, K. ; Cunningham, D....
ESMO Open.  3 (2018)  - p. A415 , 2018
Link: https://doi.org/10.1136/..
 
?
7

Genetic variants of DNA repair-related genes predict effica..:

Suenaga, M. ; Schirripa, M. ; Cao, S....
Annals of Oncology.  28 (2017)  5 - p. 1015-1022 , 2017
Link: https://doi.org/10.1093/..
 
?
8

EP-1298: Stereotactic radiotherapy in oligometastatic patie..:

Montrone, S. ; Vivaldi, C. ; Coraggio, G....
Radiotherapy and Oncology.  119 (2016)  - p. S609 , 2016
Link: https://doi.org/10.1016/..
 
?
9

Glycolysis gene expression analysis and selective metabolic..:

Graziano, F ; Ruzzo, A ; Giacomini, E...
The Pharmacogenomics Journal.  17 (2016)  3 - p. 258-264 , 2016
Link: https://doi.org/10.1038/..
 
?
10

Challenging chemoresistant metastatic colorectal cancer: th..:

Sartore-Bianchi, A. ; Loupakis, F. ; Argilés, G..
Annals of Oncology.  27 (2016)  8 - p. 1456-1466 , 2016
Link: https://doi.org/10.1093/..
 
?
11

CXCR4 polymorphism predicts progression-free survival in me..:

Matsusaka, S ; Cao, S ; Hanna, D L...
The Pharmacogenomics Journal.  17 (2016)  6 - p. 543-550 , 2016
Link: https://doi.org/10.1038/..
 
?
12

Variant alleles in factor V, prothrombin, plasminogen activ..:

Falvella, F S ; Cremolini, C ; Miceli, R...
The Pharmacogenomics Journal.  17 (2016)  4 - p. 331-336 , 2016
Link: https://doi.org/10.1038/..
 
?
13

Comprehensive Cancer Care Networks: A realistic model for o..:

Luzzatto, L ; Loupakis, F
European Journal of Public Health.  26 (2016)  suppl_1 - p. , 2016
Link: https://doi.org/10.1093/..
 
?
14

2190 Discovery of new molecular subtypes of non-hypermutate..:

Pietrantonio, F. ; Perrone, F. ; Cremolini, C....
European Journal of Cancer.  51 (2015)  - p. S396-S397 , 2015
Link: https://doi.org/10.1016/..
 
?
15

2027 KRAS status and risk of venous thromboembolic events i..:

Rihawi, K. ; Fontanella, C. ; Rossini, D....
European Journal of Cancer.  51 (2015)  - p. S337 , 2015
Link: https://doi.org/10.1016/..
 
1-15